Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Deferred Taxes: 2017-2024

Historic Deferred Taxes for Kiniksa Pharmaceuticals International (KNSA) over the last 8 years, with Dec 2024 value amounting to $8.1 million.

  • Kiniksa Pharmaceuticals International's Deferred Taxes rose 216.16% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 146.49%. This contributed to the annual value of $8.1 million for FY2024, which is 124.07% up from last year.
  • As of FY2024, Kiniksa Pharmaceuticals International's Deferred Taxes stood at $8.1 million, which was up 124.07% from -$33.8 million recorded in FY2023.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Deferred Taxes ranged from a high of $8.1 million in FY2024 and a low of -$185.5 million during FY2022.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Deferred Taxes had a median value of -$33.8 million in 2023 and averaged -$70.4 million.
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Deferred Taxes soared by 238.18% in 2020 and then crashed by 1,686,418.18% in 2022.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Deferred Taxes (Yearly) stood at $4.4 million in 2020, then crashed by 99.75% to $11,000 in 2021, then slumped by 1,686,418.18% to -$185.5 million in 2022, then soared by 81.78% to -$33.8 million in 2023, then soared by 124.07% to $8.1 million in 2024.